Articles by tag: bulevirtide

FDA approved bulevirtide (Hepcludex): treatment of hepatitis delta in the USA

FDA approved the first US drug for hepatitis delta — bulevirtide (Hepcludex). Learn about dosage, risks, price, and prognosis. Read the full analysis.

Bulevirtide (Hepcludex®): FDA approval for hepatitis D

FDA approved the first drug for chronic hepatitis D — bulevirtide. Mechanism, doses, risks, price, and prognosis. Find out who is suitable for therapy.